98 related articles for article (PubMed ID: 17766630)
1. Eppur si muove, or COPD treatment success and inflammation.
Soriano JB; Barnes NC
Eur Respir J; 2007 Sep; 30(3):409-10. PubMed ID: 17766630
[No Abstract] [Full Text] [Related]
2. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.
Powrie DJ; Wilkinson TM; Donaldson GC; Jones P; Scrine K; Viel K; Kesten S; Wedzicha JA
Eur Respir J; 2007 Sep; 30(3):472-8. PubMed ID: 17504798
[TBL] [Abstract][Full Text] [Related]
3. [Air trapping in COPD].
Mitfessel H
Krankenpfl J; 2005; 43(4-6):117. PubMed ID: 16171063
[No Abstract] [Full Text] [Related]
4. After UPLIFT: smoking cessation remains the best intervention in smokers with COPD.
Chen-Yuan C
Int J Tuberc Lung Dis; 2009 Feb; 13(2):151-2. PubMed ID: 19146740
[No Abstract] [Full Text] [Related]
5. Inhaled steroids and COPD.
Cooper CB; Decramer M
Eur Respir J; 2008 Aug; 32(2):523-4. PubMed ID: 18669794
[No Abstract] [Full Text] [Related]
6. Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes.
Yohannes AM; Willgoss TG; Vestbo J
Respir Care; 2011 Apr; 56(4):477-87. PubMed ID: 21255503
[TBL] [Abstract][Full Text] [Related]
7. UPLIFTing care for chronic obstructive pulmonary disease.
Davies L; Calverley PM
Lancet; 2009 Oct; 374(9696):1129-30. PubMed ID: 19716599
[No Abstract] [Full Text] [Related]
8. [Debates surrounding COPD].
Tillie-Leblond I; Housset B
Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
[No Abstract] [Full Text] [Related]
9. Tiotropium (Spiriva) for COPD.
Hutton SF
Am Fam Physician; 2004 Jun; 69(12):2901-2. PubMed ID: 15222656
[No Abstract] [Full Text] [Related]
10. [Early diagnosis, Uplift and COPD in stage II].
Mihălţan F; Ulmeanu R
Pneumologia; 2009; 58(4):263-5. PubMed ID: 20067063
[No Abstract] [Full Text] [Related]
11. New COPD medications seem okay for the heart.
Harv Heart Lett; 2008 Dec; 19(4):7. PubMed ID: 19090044
[No Abstract] [Full Text] [Related]
12. Exacerbation of chronic obstructive pulmonary disease: pan-airway and systemic inflammatory indices.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Proc Am Thorac Soc; 2006 Aug; 3(6):481-2. PubMed ID: 16921117
[No Abstract] [Full Text] [Related]
13. Choice of bronchodilator therapy for patients with COPD.
Wedzicha JA
N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773
[No Abstract] [Full Text] [Related]
14. COPD and declining FEV1--time to divide and conquer?
Reilly JJ
N Engl J Med; 2008 Oct; 359(15):1616-8. PubMed ID: 18836214
[No Abstract] [Full Text] [Related]
15. [2005 Robert Koch Award for tiotropium. Quality leap in therapy of COPD].
MMW Fortschr Med; 2005 May; 147(19):55. PubMed ID: 15940942
[No Abstract] [Full Text] [Related]
16. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
Izquierdo Alonso JL
An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
[TBL] [Abstract][Full Text] [Related]
17. [Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease].
Corhay JL; Louis R
Rev Med Suisse; 2005 Aug; 1(30):1967-9, 1971-2. PubMed ID: 16200941
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium in chronic obstructive pulmonary disease.
Sierra-Sánchez JF; Alegre-del Rey EJ; Cobo I
N Engl J Med; 2009 Jan; 360(2):186-7; author reply 187. PubMed ID: 19137625
[No Abstract] [Full Text] [Related]
19. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].
MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817
[No Abstract] [Full Text] [Related]
20. The role of tiotropium in the hospital management of exacerbation of chronic obstructive pulmonary disease.
Tashkin DP
Respir Care; 2008 Dec; 53(12):1657-9. PubMed ID: 19025697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
